Patents by Inventor Hansaem JEONG

Hansaem JEONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ionizable lipid compounds, lipid nanoparticles comprising same and therapeutic uses thereof
    Patent number: 11911485
    Abstract: The present invention relates to lipid nanoparticles for in vivo drug delivery and uses thereof, and the lipid nanoparticle are liver tissue-specific, have excellent biocompatibility and can deliver a gene therapeutic agent with high efficiency, and thus it can be usefully used in related technical fields such as lipid nanoparticle mediated gene therapy.
    Type: Grant
    Filed: August 1, 2022
    Date of Patent: February 27, 2024
    Assignee: EnhancedBio Inc.
    Inventors: Hyukjin Lee, Minjeong Kim, Hansaem Jeong, Hyokyoung Kwon, Yunmi Seo, Michaela Jeong
  • IONIZABLE LIPID COMPOUNDS, LIPID NANOPARTICLES COMPRISING SAME AND THERAPEUTIC USES THEREOF
    Publication number: 20230310644
    Abstract: The present invention relates to lipid nanoparticles for in vivo drug delivery and uses thereof, and the lipid nanoparticle are liver tissue-specific, have excellent biocompatibility and can deliver a gene therapeutic agent with high efficiency, and thus it can be usefully used in related technical fields such as lipid nanoparticle mediated gene therapy.
    Type: Application
    Filed: August 1, 2022
    Publication date: October 5, 2023
    Inventors: Hyukjin LEE, Minjeong KIM, Hansaem JEONG, Hyokyoung KWON, Yunmi SEO, Michaela JEONG
  • Lipid nanoparticles for in-vivo drug delivery, and uses thereof
    Patent number: 11464870
    Abstract: The present invention relates to lipid nanoparticles for in vivo drug delivery and uses thereof, and the lipid nanoparticle are liver tissue-specific, have excellent biocompatibility and can deliver a gene therapeutic agent with high efficiency, and thus it can be usefully used in related technical fields such as lipid nanoparticle mediated gene therapy.
    Type: Grant
    Filed: October 19, 2021
    Date of Patent: October 11, 2022
    Assignee: ENHANCEDBIO INC.
    Inventors: Hyukjin Lee, Minjeong Kim, Hansaem Jeong, Hyokyoung Kwon, Yunmi Seo, Michaela Jeong
  • LIPID NANOPARTICLES FOR IN-VIVO DRUG DELIVERY, AND USES THEREOF
    Publication number: 20220040325
    Abstract: The present invention relates to lipid nanoparticles for in vivo drug delivery and uses thereof, and the lipid nanoparticle are liver tissue-specific, have excellent biocompatibility and can deliver a gene therapeutic agent with high efficiency, and thus it can be usefully used in related technical fields such as lipid nanoparticle mediated gene therapy.
    Type: Application
    Filed: October 19, 2021
    Publication date: February 10, 2022
    Inventors: Hyukjin LEE, Minjeong KIM, Hansaem JEONG, Hyokyoung KWON, Yunmi SEO, Michaela JEONG